UC BON.CAP.CERT. 03/25 OMV/ DE000HD41WL9 /
2025-01-03 9:46:05 PM | Chg.+0.180 | Bid9:59:08 PM | Ask9:59:08 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
54.800EUR | +0.33% | 54.670 Bid Size: 1,000 |
55.000 Ask Size: 1,000 |
OMV AG | - EUR | 2025-03-28 | Call |
GlobeNewswire
2024-03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
2024-01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center